Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guo-Ming Shi

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|May 27, 2026
Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma. ReplyFei Liang, Guo-Ming Shi, Jia Fan
BMC Cancer|November 4, 2015
Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studiesHao Cai, Wen-Tao Kong, Chao-Bo Chen, et al.
Oncology Letters|February 13, 2014
Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinomaJia-Hao Jiang, Qiang Gao, Ai-Wu Ke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2009
A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasmsTao Li, Yuan Ji, Xu-Ting Zhi, et al.
Molecular Cancer|May 14, 2021
CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivityZhao-Ru Dong, Ai-Wu Ke, Tao Li, et al.
Annals of Translational Medicine|April 21, 2020
Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinomaGuang-Yu Ding, Xiao-Dong Zhu, Yuan Ji, et al.
Molecular Cancer|June 29, 2020
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinomaPeng-Fei Zhang, Chao Gao, Xiao-Yong Huang, et al.
BMC Cancer|January 19, 2017
Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or BCheng Huang, Xiao-Dong Zhu, Yuan Ji, et al.
Surgery|October 24, 2018
Dexamethasone for postoperative hyperbilirubinemia in patients after liver resection: An open-label, randomized controlled trialCheng Huang, Xiao-Dong Zhu, Guo-Ming Shi, et al.
Plos One|January 26, 2013
Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinomaChi Zhang, Dou-Sheng Bai, Xiao-Yong Huang, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|May 27, 2026
Neoadjuvant GOLP in Intrahepatic Cholangiocarcinoma. ReplyFei Liang, Guo-Ming Shi, Jia Fan
BMC Cancer|November 4, 2015
Cholelithiasis and the risk of intrahepatic cholangiocarcinoma: a meta-analysis of observational studiesHao Cai, Wen-Tao Kong, Chao-Bo Chen, et al.
Oncology Letters|February 13, 2014
Prognostic significance of nuclear RNA export factor 3 in hepatocellular carcinomaJia-Hao Jiang, Qiang Gao, Ai-Wu Ke, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2009
A comparison of hepatic mucinous cystic neoplasms with biliary intraductal papillary neoplasmsTao Li, Yuan Ji, Xu-Ting Zhi, et al.
Molecular Cancer|May 14, 2021
CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivityZhao-Ru Dong, Ai-Wu Ke, Tao Li, et al.
Annals of Translational Medicine|April 21, 2020
Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinomaGuang-Yu Ding, Xiao-Dong Zhu, Yuan Ji, et al.
Molecular Cancer|June 29, 2020
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinomaPeng-Fei Zhang, Chao Gao, Xiao-Yong Huang, et al.
BMC Cancer|January 19, 2017
Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or BCheng Huang, Xiao-Dong Zhu, Yuan Ji, et al.
Surgery|October 24, 2018
Dexamethasone for postoperative hyperbilirubinemia in patients after liver resection: An open-label, randomized controlled trialCheng Huang, Xiao-Dong Zhu, Guo-Ming Shi, et al.
Plos One|January 26, 2013
Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinomaChi Zhang, Dou-Sheng Bai, Xiao-Yong Huang, et al.
Pageof 10